Then, we investigated the potential therapeutic effects of minocycline on the expression of two effective genes (CMKLR1 and INSR) in inflammation and glucose metabolism, hormonal profile, and ovarian histology in the PCOS NMRI mouse model. Here, CMKLR1 is linked to polycystic ovary syndrome.